Management Software for the Elaboration of an Electronic File in the Pharmaceutical Industry Following Mexican Regulations

Authors: M. Peña Aguilar Juan, Ríos Hernández Ezequiel, R. Valencia Luis

Abstract:

For certification, certain goods of public interest, such as medicines and food, it is required the preparation and delivery of a dossier. For its elaboration, legal and administrative knowledge must be taken, as well as organization of the documents of the process, and an order that allows the file verification. Therefore, a virtual platform was developed to support the process of management and elaboration of the dossier, providing accessibility to the information and interfaces that allow the user to know the status of projects. The development of dossier system on the cloud allows the inclusion of the technical requirements for the software management, including the validation and the manufacturing in the field industry. The platform guides and facilitates the dossier elaboration (report, file or history), considering Mexican legislation and regulations, it also has auxiliary tools for its management. This technological alternative provides organization support for documents and accessibility to the information required to specify the successful development of a dossier. The platform divides into the following modules: System control, catalog, dossier and enterprise management. The modules are designed per the structure required in a dossier in those areas. However, the structure allows for flexibility, as its goal is to become a tool that facilitates and does not obstruct processes. The architecture and development of the software allows flexibility for future work expansion to other fields, this would imply feeding the system with new regulations.

Keywords: Electronic dossier, technologies for management, web software, dossier elaboration, pharmaceutical industry.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1129678

References:

[1] R.- ASALE, “Spanish dictionary - Edición del Tricentenario,” Diccionario de la lengua española. (Online). Available: http://dle.rae.es/?w=diccionario. (Accessed: 15-Feb-2017).
[2] M. Nouman, “Software Build History Dossier for Development and Testing,” Department of Electrical Engineering A thesis submitted in partial fulfillment of the requirements for the degree of Masters in Computer and Communication Security (MS CCS) In School of Electrical Engineering and Computer Science, National University of Sciences and Technology, 2016.
[3] M. K. Chemuturi and T. M. C. Jr, Mastering Software Project Management: Best Practices, Tools and Techniques. Ft. Lauderdale, FL: J. Ross Publishing, 2010.
[4] “Writings on Archives, Historical Manuscripts, and Current Records: 1984,” Am. Arch., vol. 49, no. 4, pp. 425–535, Oct. 1986.
[5] United States of Mexico, Secretary of Health, Official Gazette of the Federation. General Health Law, Ministry of Health, June 14, 1992.
[6] COFEPRIS. (2015) Regulations for inputs for health.
[7] COFEPRIS. (2016) Federal Commission for Protection against health risks.
[8] Presidency of the Republic (1988) Regulation of the General Health Law on Sanitary Control of Activities, Establishments, Products and Services, United Mexican States; Official Journal of the Federation.
[9] Committee of New Molecules of the Federal Commission for Protection against Health Risks (2008) Internal Regulations of the New Molecules Committee, United Mexican States; Official Journal of the Federation.
[10] National Consultative Committee for Standardization of Health Regulation and Development (2013) NOM-059-SSA1-2013, Good Manufacturing Practices of Medicines, United Mexican States; Official Journal of the Federation.
[11] National Advisory Committee for Standardization of Health Regulation and Development (2012) NOM-072-SSA1-2012, Labeling of Medicines and Herbal Remedies, United Mexican States; Official Journal of the Federation.
[12] National Advisory Committee on Standardization of Health Regulation and Development (2005) NOM-073-SSA1-2005, Stability of Drugs and Medicines, United Mexican States; Official Journal of the Federation.
[13] National Advisory Committee on Standardization of Health Regulation and Development (2008) NOM-137-SSA1-2008, Labeling of Medical Devices, United Mexican States; Official Journal of the Federation.
[14] National Consultative Committee for Standardization of Regulation and Health Promotion (2013) NOM-164-SSA1-2013, Good Manufacturing Practices for Drugs, United Mexican States; Official Journal of the Federation.
[15] National Consultative Committee for Standardization of Health Regulation and Development (1998) NOM-176-SSA1-1998, Sanitary Requirements to be met by Manufacturers, Distributors and Suppliers of Drugs Used in the Preparation of Medicines for Human Use, United Mexican States; Official Journal of the Federation.
[16] National Advisory Committee on Standardization of Health Regulation and Development (1998) NOM-177-SSA1-1998, Establishing the Evidence and Procedures to Demonstrate that a Medication is Interchangeable. Requirements to be Subject to Authorized Third Parties Performing the Tests, United Mexican States; Official Journal of the Federation.
[17] National Advisory Committee on Standardization of Health Regulation and Development (2002) NOM-220-SSA1-2002, Installation and Operation of Pharmacovigilance, United Mexican States; Official Journal of the Federation.
[18] National Advisory Committee for Standardization of Health Regulation and Development (2002) NOM-249-SSA1-2010, Sterile Mixtures: Nutrition and Medications, and Facilities for Preparation, United Mexican States; Official Journal of the Federation.
[19] National Consultative Committee for Standardization of Health Regulation and Development (2013) NOM-257-SSA1-2013, Authorization of Medicines, Registration, Renewal and Modifications, United Mexican States; Official Journal of the Federation.
[20] COFEPRIS (2016) Guidelines for the Validation of Good Manufacturing Practices, Mexico City.
[21] COFEPRIS (2016) Guidelines Establishing Requirements for Change of Drug Manufacturer or Inclusion of Alternate Manufacturers, Mexico City.
[22] COFEPRIS (2016) Guidelines for the Use of Distinctive Denominations of Medicines, Mexico City.
[23] AGREEMENT by which modifies the miscellaneous that discloses the procedures and services, as well as the formats applied by the Ministry of Health, through the Federal Commission for Protection against Sanitary Risks, registered in the Federal Register of Procedures and Services of the Federal Commission for Regulatory Improvement, published on January 28, 2011.
[24] COFEPRIS (2016) Health Surveillance Report to the Secretariat of Public Service, COFEPRIS.
[25] Informe Pro México para la Industria Farmacéutica 2015. Tomado de: http://www.promexico.gob.mx/documentos/diagnosticos-sectoriales/farmaceutico.pdf. Accessed on: 27/10/2016
[26] COFERPIS (2015) Instructive to fill the format of notice of operation, sanitary and modification or low.
[27] COFEPRIS. (2015) Instruction for filling the Authorizations, Certificates and Visits format